AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-255023750/idera-pharmaceuticals-delays-initiation.html" title="Facts and information about Idera Pharmaceuticals delays initiation of Phase II clinical trial of IMO-2125 in treatment-naive HCV patients.">Idera Pharmaceuticals delays initiation of Phase II clinical trial of IMO-2125 in treatment-naive HCV patients.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Idera Pharmaceuticals delays initiation of Phase II clinical trial of IMO-2125 in treatment-naive HCV patients.
Idera Pharmaceuticals Inc announced that it has chosen to delay initiating its planned Phase II clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase II clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naive, genotype 1 hepatitis C virus (HCV) patients. …
Related articles from newspapers, magazines, journals, and more
-
- Idera Pharmaceuticals initiates Phase I clinical trial of IMO-2125, a TLR9...
-
News wire article from: Chemical Business Newsbase
October 7, 2009
700+ words
-
- Idera Pharmaceuticals initiates Phase I clinical trial of IMO-3100, a...
-
News wire article from: Chemical Business Newsbase
January 28, 2010
700+ words
-
- Idera Pharmaceuticals announces preliminary data from Phase I clinical trial...
-
News wire article from: Chemical Business Newsbase
December 20, 2010
700+ words
-
- Idera Pharmaceuticals presents final data from Phase II clinical trial of...
-
News wire article from: Chemical Business Newsbase
September 25, 2009
700+ words
-
- Idera Pharmaceuticals presents data from a Phase I clinical trial of IMO-2125...
-
News wire article from: Chemical Business Newsbase
April 2, 2011
700+ words
